Clinical Trials Browser

Anatomic Stage IV Breast Cancer AJCC v8 × trastuzumab deruxtecan × 90 days × Clear all

NCT07578116 2026-05-27

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

Phase 3 Not yet recruiting

Anatomic Stage IV Breast Cancer AJCC v8